SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-222023
Filing Date
2012-05-09
Accepted
2012-05-09 16:10:11
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d334408d10q.htm 10-Q 664930
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULES 13A-14 OR 15D-14 d334408dex311.htm EX-31.1 6670
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULES 13A-14 OR 15D-14 d334408dex312.htm EX-31.2 6666
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULES 13A-14(B) d334408dex321.htm EX-32.1 3559
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULES 13A-14(B) d334408dex322.htm EX-32.2 3555
  Complete submission text file 0001193125-12-222023.txt   2218362

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tsrx-20120331.xml EX-101.INS 285511
7 XBRL TAXONOMY EXTENSION SCHEMA tsrx-20120331.xsd EX-101.SCH 12369
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tsrx-20120331_cal.xml EX-101.CAL 29820
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tsrx-20120331_lab.xml EX-101.LAB 101273
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tsrx-20120331_pre.xml EX-101.PRE 64322
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34828 | Film No.: 12825840
SIC: 2834 Pharmaceutical Preparations